DLC1 inhibits colon adenocarcinoma cell migration by promoting secretion of the neurotrophic factor MANF ... DLC1 (deleted in liver cancer-1) is downregulated or ...
... org/1998/Math/MathML" xmlns:xlink="http://www.w3 ... Oncol.</journal-id> <journal-title>Frontiers in ... <article-title>Full activity of the deleted in liver cancer ...
Highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis, ...
Missing: 2022.900166/ | Show results with:2022.900166/
DLC1 was found to repress PTHLH transcription and secretion and eventually lead to decrease breast cancer bone metastasis (7). We were wondering if DLC1 ...
Highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis, ...
Missing: 2022.900166/ full
Mechanistically, DLC1 reduced the retention of MANF in ER by competing the interaction between MANF and GRP78. Taken together, these data provided new insights ...
Frontiers in Oncology, Vol 12 (2022). مصطلحات ... Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.900166/full; https://doaj.org/toc/2234-943X.
Research has found that cancer and metastases exhibit abnormal expression of numerous non-coding RNA. Some of these RNA facilitate prostate ...
Missing: 2022.900166/ | Show results with:2022.900166/
https://doi.org/10.3389/fonc.2022.900166 ·. 2022, Frontiers in Oncology. Scopus. WoS. Crossref citations: 0 · MicroRNA-106b promotes colorectal cancer cell ...
Missing: articles/ | Show results with:articles/
IntroductionPembrolizumab combined with chemotherapy has become the standard of care for patients with non-small-cell lung cancer (NSCLC) ...
Missing: 2022.900166/ | Show results with:2022.900166/